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L. antarcticum merupakan spesis yis yang dijumpai di Antartika. Dengan 
adaptasi spesifik yang membolehkannya hidup dalam suasana sejuk serta mencabar di 
Antartika, L. antarcticum mempunyai potensi untuk pelbagai aplikasi seperti protein 
anti-beku dan juga ciri-ciri lain yang berguna. Saiz genom untuk L. antarcticum 
adalah 14 Mb. Dalam penyelidikan ini, kami menggunakan vector plasmid untuk 
membina perpustakaan genetik L. antarcticum dalam strain E. coli Top Ten. L. 
antarcticum ditumbuhkan dalam media cecair YPD sebelum diasingkan. Tiga kaedah 
dibandingkan untuk mengekstrak DNA daripada L. antarcticum (kaedah pemecahan 
protein Proteinaise K, kaedah pemecahan protein Proteinaise K + Pronase and juga 
kaedah pemecahan nitrogen cecair). Kami mendapati kaedah pemecahan nitrogen 
cecair merupakan kaedah yang terbaik untuk digunakan bagi mengekstrak dan 
memecahkan DNA L. antarcticum pada saiz 1000 hingga 2000 bp. DNA ditulenkan 
bagi mendapat pecahan DNA pada saiz 1000 bp hingga 1500 bp. DNA yang 
ditulenkan dibaiki, didefosforilasikan dan dimasukkan ke dalam vektor pCR®4Blunt-
TOPO® DNA berhujung tumpul. Plasmid rekombinan kemudian ditransformasi ke 
dalam E. coli menggunakan kaedah rejatan haba sebelum dikulturkan pada agar LB. 
Pengekstrakan plasmid dilakukan untuk melihat kehadiran serpihan DNA selitan. 
Kesimpulannya, kami berjaya menghasilkan lebih kurang 2976 klon E. coli iaitu 
merupakan 31.9 % daripada keseluruhan genom L. antarcticum. 
X 
Abstract 
L. antarcticum is a yeast species found in Antarctica. With special adaptation 
to survive in cold harsh environment of Antarctica, L. antarcticum have various 
potential applications like antifreeze proteins and useful features. The genome size of 
L. antarcticum is approximately 14 Mb. In this research, we tried to construct a gene 
library for L. antarcticum by using plasmid vector. L. antarcticum was cultivated in 
YPD broth before harvested. Three methods were evaluated for DNA extraction from 
L. antarcticum (Proteinaise K proteolytic lysis method, Proteinaise K + Pronase 
proteolytic lysis method and also liquid nitrogen lysis method). We found that liquid 
nitrogen lysis method was the best method to extract and fragmentize the L. 
antarcticum DNA at the required size of 1000 bp to 1500 bp. They were then purified 
to obtain DNA fragment of 1000 bp to 1500 bp. The purified DNA were repaired, 
dephosphorylated and inserted into pCR®4Blunt-TOPO® DNA vector. The 
recombinant plasmids were fmally transformed into Top Ten E. coli strain using heat 
shock before plated on LB agar. Plasmid extractions were carried out on clones to 
screen for presence of DNA insert. In conclusion, this study managed to construct a 
gene library containing approximately 2976 E. coli clones which cover 31.9 % of the 
whole L. antarcticum genome. 
xi 
Chapter One: Introduction 
1.1 Leucosporidium antarcticum (L. antarcticum) 
Leucosporidium antarcticum is a species of fungi found in the cold region of 








Table 1: L. antarcticum taxonomy (Fell et al, 1969). 
Leucosporidium antarcticum is a cellular eukaryote organism of kingdom 
Fungi, phylum Basidiomycota, class Pucciniomycotina, order Microbotryomycetes, 
family Leucosporidiales, genus Leucosporidium; species antarcticum. (Fell et al, 1969) 
Figure 1: Leucosporidium antarcticum at 100 X magnification. (Light microscopy) 
1.2 Characteristic of L. antarcticum 
Leucosporidium antarcticum is an obligate psychrophilic, budding, non-sugar-
fermenting, halotolerant marine yeast (Marzena eta/, 2003). These fungi require cold 
environment to grow and survive. They reproduce by budding process similar to yeast. 
Leucosporidium antarcticum thrive in salty cold environment of Antarctic Sea. 
The natural habitat of L. antarcticum has NaCl concentration of 2.5 to 3.5 % 
(Marzena et al, 2003). The highest concentration protein derived from this organism is 
at this concentration as NaCl play a role in enzyme biosynthesis (Marzena et al, 2003). 
Physical examinations by microscope reveal that this organism has yeast like 
morphology with the width of2.1 to 2.7 urn and length of2.9 to 4.0 urn thus making it 
appeared as a bit oval in shape. 
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L. antarcticum are able to utilize various sugars present in the medium 
(maltose, sucrose) and also tributyrin as basic as carbon source (Marianna et al, 2003). 
It is noted that this organism is a non sugar fermenter. 
This yeast secretes extracellular proteolytic enzyme, hydrolases and also lipase 
into its surrounding (Marianna et al, 2003). 
Interestingly, it is able to grow in nitrogen free media where the only source of 
nitrogen is molecular nitrogen from the atmosphere, possibly this might be due to the 
yeast ability to utilize nitrogen from the atmosphere directly (Abdul et al, 2007). 
Another possible explanation for this characteristic is that this yeast lives in symbiosis 
with a prokaryote that can utilize and fix molecular nitrogen directly from atmosphere. 
The ability for organism to fix molecular nitrogen from atmosphere into biologically 
usable compound is a process restricted to some bacteria (Christoph et al, 2007). 
The genome size of L. antarcticum is estimated to be around 10.5 to 14 Mb 
with nearly 76 % of gene analyzed is fungal in origin while the rest of it has similarity 
to genes from other group of organism (Abdul et al, 2007). Interestingly, 8% of this 
yeast gene is similar to bacterial genes which are speculated to exist due to lateral 
gene transfer from bacteria to L. antarcticum or another possible explanation is that 
bacteria live in symbiosis with this yeast. Apart from this discovery, researcher also 
manage to uncover existence of several distinctive gene that codes for putative anti 
freeze protein, ice binding protein, lipase, protease etc (Abdul et al, 2007). Possibly 
these genes granted the yeast the needed advantage to survive in extreme cold region 
of Antarctica and possibly other undiscovered use yet. 
These psychrophilic organisms were discovered in cold condition between 
altitude 60S and 90S which encompass the Antarctica region (Marzena et al, 2003). 
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Some biological process of this yeast while similar to organism existing in 
normal temperature region have special kinetic and features that enable efficient 
function and survival in cold energy deficient environment (Marzena et al, 2003). 
From other publications, it is noted that this yeast will not thrive in warm condition. It 
is noted that while the enzymes is adapted for maximum efficiency in cold 
environment, it is heat labile and would prevent the yeast from thriving in higher 
temperature. The L. antarcticum is a yeast that are specially adapted to survive in cold 
environment and thus are able to secure a habitat without intrusion from normal 
organism that could not survive the Antarctic freezing condition. 
This antartic yeast has heat shock mechanism analogous to mesophilic yeast 
counterpart but with distinct protein stress protein profile favoring their survival in 
hostile Antartic condition (Michelle et al, 1998) 
1.3 Scientific finding that enable L. antarcticum to survive in 
Antarctica 
Antarctica lies in Antarctic circle that encompasses area of between latitude 66 
S to latitude 90S (Barry et al, 2004). Due to its position on earth, Antarctica received 
less overall sum of energy per unit surface compared to equator region. This resulted 
in extremely low temperature which is the normal condition all year around. 
This is a very challenging place to live but many organisms managed not only 
to survive but adapted to thrive in this extreme condition. Challenges include rapid 
temperature changes which may cause repeated rapid freezing and thawing that will 
kill most unadapted organisms. 
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Low temperature affects organism by slowing down or inhibiting chemical 
reaction rates that catalyzes the biological process occurring in the organism (Salvino 
et al, 2002). 
Several strategies that are usually employed by psychrophilic yeast include 
alteration of membrane lipid composition. By altering the degree of fatty acid 
unsaturation in the cell membrane, this reduces the damage caused by repeated 
freezing and thawing on the yeast cell (Serena et al, 2007). This alteration maintains 
membrane fluidity which allow the cell membrane to function normally even in 
freezing condition (Barry et al, 2004). This alteration also increases the efficiency of 
nutrient uptake at cold temperature in organism of cold origin while maintaining cell 
integrity (Barry et al, 2004). 
Some of the Antarctic fungi synthesize cryoprotective carbohydrate (trehalose, 
mannitol, etc) that function to stabilize the membrane of yeast from cold damage 
(Serena et al, 2007). It is suggested that these cryoprotectant play a role in altering 
ions permeability and also altering water structure in the environment whether 
intercellular or extracellular allowing some control on water crystallization that lead 
to ice crystal formation in cold environment (Serena et al, 2007). Damaging ice 
crystal formation could be avoided in order to reduce cell injury. 
Some Antarctic organisms synthesize antifreeze protein that act by preventing 
ice crystal formation thus preventing cell injury and enhance survival in frigid climate 
(Barry et al, 2004 ). These antifreeze proteins alter ice crystal formation by preventing 
ice crystal growth. 
Another strategy used by L. antarcticum is the alteration of the enzyme and 
protein to be able to function efficiently in cold environment. A study on a protein of 
this yeast called serine proteinase derived from L. antarcticum shows that the protein 
5 
have low optimal temperature (25 °C), functioned at 0 °C, thermolabile, has high 
catalytic efficiency and low value of activation energy (Marzena et al, 2003). 
Psychrophilic organisms usually synthesize enzymes with higher specific activity at 
low and medium activity (Salvano et al, 2003). However, the synthesized enzymes are 
highly thermolabile and not efficient at tropical room temperature compared to 
tropical organism (Salvano et al, 2003 ). 
1.4 The purpose of this work 
Due to its ability to grow in extreme low temperature, this yeast generates 
research interest for various applications. Among these include catalytic protein 
encoded by this organism that work in low temperature efficiently unlike normal 
protein that require normal high optimum temperature to function at maximum 
efficiency. 
Another possible application is in the field of cryobiology. Glycoprotein 
produced by L. antarcticum shows a partial benefit in improving rat liver preservation 
in conjunction with the presence of other preserving agent (Tilsver et al, 1996). 
In order to begin studying the characteristic of Leucosporidium antarcticum (L. 
antarcticum) molecular origin, a gene library representing the whole Leucosporidium 
antarcticum (L. antarcticum) have to be constructed so that its entire DNA sequence 
could be mapped. This approach enable scientist to determine the number of 
functional protein coding gene (Ursula and Blomberg, 2006). 
The first objective is to find the best cultivation condition that allows the yeast 
to populate. 
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The second objective is to find the best DNA extraction method to harvest the 
DNA from the yeast. Several methods are examined for this purpose. This includes 
using proteolytic lysis buffer (Proteinaise K) with sonication method; proteolytic lysis 
buffer (Proteinaise K and Pronase A) with sonication method; and the last method is 
liquid nitrogen cell lysis method. 
The third objective is to construct a genomic library for L. antarcticum. 
7 
Chapter Two: Materials and methods 
2.1 Test Organism 
2.1.1 L. antarcticum strain 
The L. antarcticum strain used in this experiment was derived from the sample 
taken back from Antarctica in year 2002 (A gift from Prof. Mohd Nazalan Mohd 
Najimudin). 
2.1.2 E. coli strain 
The E. coli strain used in this experiment is from Top Ten One Shot 
Chemically Competent E. coli genotype F- mcrA ~(mrr-hsdRMS-mcrBC) 
fb80lacZ~M15 ~lacX74 recAl araD139 ~(araleu) 7697 ga/U ga/K rpsL (StrR) 
endA 1 nupG from Invitrogen for general cloning and blue/white screening without 
IPTG. (Invitrogen) (Siah, 2007) 
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2.2 Media, buffer and solution preparation 
2.2.1 Ampicillin stock preparation (50 mglml) 
500 mg Ampicillin (Pharmmalaysia, Malaysia) were measured and dissolved 
into 10 ml sterile ddH20 in a 15 ml falcon tube. The solution was filtered by using 0.2 
urn Milipore filter in a laminar air flow and aliquoted into 1 ml microcentrifuge tube. 
The microcentrifuge tubes were labeled and stored at -20 °C. 
2.2.2 Kanamycin stock preparation (50 mglml) 
500 mg Kanamycin (Amresco, USA) were measured and dissolved into 10 ml 
sterile ddH20 in a 15 ml falcon tube. The solution was filtered by using 0.2 urn 
Milipore filter in a laminar air flow and aliquoted into I ml microcentrifuge tubes. 
The microcentrifuge tubes were labeled and stored at -20 °C. 
2.2.3 25 °/o Glucose stock solution preparation (50 ml) 
12.5 g of glucose (R&M Chemicals, UK) were measured and dissolved into 50 
ml of sterile ddH20 in a 50 ml falcon tube. The solution was filtered by using 0.2 urn 
Milipore filter in a laminar air flow into a new 50 ml sterile falcon tube and stored at 4 
oc. 
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2.2.4 Tris HCI pH 8.0 preparation (100 ml) 
15.76 g of Tris Cl (Promega, USA) were measured. ddH20 was added until 
the volume reached 100 ml. The pH were adjusted to pH 8.0 using 5 M NaOH and 
stored at room temperature. 
2.2.5 10 % (w/v) SDS solution preparation 
10 g of SDS (Bio-Rad, USA) were dissolved in 100 ml ddH20. Solution was 
heated to 65 °C for 20 minute and stored at room temperature. 
2.2.6 Proteinaise K preparation (1 0 mglml) 
10 mg of Proteinaise K (Boeringer Manheim, Germany) were dissolved in 1 
ml sterile ddH20. The prepared solution was aliquoted into 1.5 ml microcentrifuge 
tubes. These tubes were stored in -20 °C until use. 
2.2. 7 Pronase preparation (1 0 mglml) 
1 ml ddH20 were added to 10 mg Pronase (Boeringer Manheim, Germany) 
powder to make the final concentration of 10 mglml for the stock solution. The 
prepared solution was aliquoted into microcentrifuge tube and stored in -20 °C until 
use. 
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2.2.8 0.5 M EDTA pH 8.0 preparation (500 ml) 
93.06 g EDTA (Promega, USA) were dissolved in 300 ml of ddH20. The pH 
was adjusted to pH 8.0 using 5 M NaOH. Then ddH20 were added until the final 
solution volume is 500 ml. The prepared solution was autoclaved at 121 °C for 15 
minutes and stored at room temperature. 
2.2.9 3 M NaOAc I Sodium Acetate preparation (500 ml) 
123 g ofNaOAc (FlukaAG, Germany) were dissolved in 400 ml ddH20. Then 
ddH20 were added until the final volume is 500 ml. The prepared solution was 
autoclaved at 121 °C for 15 minutes and stored at room temperature. 
2.2.10 10 X Tris EDTA pH 8.0 buffer preparation (TE) (100 ml) 
12.1 g Tris base (Amresco, USA) and 3.7 g EDTA (Promega, USA) powder 
were dissolved in ddH20 until the final solution is 100 ml. The prepared solution was 
autoclaved at 121 °C for 15 minutes and stored at room temperature. 
2.2.11 10 X PBS preparation (400 ml) 
20 phosphate buffered saline tablets (GIBCO BRL, UK) were dissolved into 
400 ml ddH20. The prepared solution was autoclaved at 121 °C for 15 minutes and 
stored at room temperature. 
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2.2.12 SOC media preparation (50 ml) 
1 g tryptone (Amresco, USA), 0.25 g yeast extract (Amresco, USA), 0.025 g 
NaCl (Merck, Germany) were dissolved in 40 ml ddH20. 500 ul of 250 mM KCl 
were then added to the solution. pH of the solution was adjusted to 7.0 using 5 M 
NaOH. ddH20 were added until final volume is 50 ml. The prepared solution was 
autoclaved at 121 oc for 15 minutes and cooled down to 55 °C. 500 ul of sterile 1 M 
MgCh and 72 ul25% glucose were added. The prepared solution was stored at 4 °C. 
2.2.13 5 M NaCI preparation 
29.2 g of NaCl (Merck, Germany) were dissolved with ddH20 until the end 
volume is 100 mi. The prepared solution was autoclaved at 121 °C for 15 minutes and 
stored at room temperature. 
2.2.14 RNAse preparation (10 mglml) 
10 mg RNase (Fermentas, USA) were dissolved in 1 ml diluent (10 mM Tris, 
15 mM NaCl). The prepared solution was heated to 100 oc for 15 minutes before 
allowed to slowly cool down to room temperature. The solution was aliquoted into 
microcentrifuge tube and stored in- 20 °C. (Sambrook et al, 1989) 
2.2.15 5 M HCI preparation 
416 ml of 12M HCl (BDH Chemicals, UK) were added to 583 ml of ddH20. 
The prepared solution was mixed and stored at room temperature. 
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2.2.16 S M NaOH preparation 
20 g of NaOH (BDH Chemicals, UK) were dissolved in 100 ml ddH20 and 
stored at room temperature. 
2.2.17 80 o/o (w/v) glycerol preparation 
80 ml 100 % glycerol (BDH Chemicals, UK) were added to 20 ml ddH20 and 
mixed. This solution was autoclaved at 121 °C for 15 minutes and stored at room 
temperature. 
2.2.18 EtBr I Ethidium Bromide preparation (10 mglml) 
2 g of EtBr (Sigma, USA) were dissolved in 200 ml ddH20. The prepared 
solution was stored in sealed plastic container at room temperature. (Sambrook et al, 
1989) 
* Precaution for laboratory safety: 
Ethidium bromide is a powerful mutagen and is considered moderately toxic. 
Gloves should be worn when working with solutions that contain this dye. After use, 
these solutions should be decontaminated. (Sambrook et al, 1989) 
To decontaminate ethidium bromide, following procedure was employed. 
Water was added until the concentration of ethidium bromide was less than 0.5 mg/ml. 
1 volume of 0.5 M K.Mn04 was added and mixed carefully. Then 1 volume of 2.5N 
HCl was added. The solution was mixed carefully and left to stand at room 
temperature for several hours. Then 1 volume of 2.5N NaOH was added and mixed. 
The solution was discarded. (Sambrook et al, 1989) 
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2.2.19 250 mM MgCh preparation (100 ml) 
5.083 g MgCh (Amresco, USA) were dissolved in 70 ml ddH20. Then ddH20 
were added until the final volume is 1 00 ml. This solution was autoclaved at 121 °C 
for 15 minutes and stored at room temperature. 
2.2.20 1 M CaCh preparation (1 00 ml) 
14.7 g CaCh (Amresco, USA) were dissolved in 70 ml ddH20. Then ddH20 
were added until the final volume is 100 ml. This solution was autoclaved at 121 oc 
for 15 minutes and stored at room temperature. 
2.2.21 lOX TBE stock solution preparation (1000 ml) 
108 g ofTris base (Amresco, USA), 55 g of Boric acid (Promega, USA) and 
40 ml 0.5 M EDTA pH 8.0 were measured and mixed into 200 ml sterile ddH20 in a 
1 L bottle. After the solid have dissolved completely, ddH20 were added until the 
volume is reached 1000 ml. The prepared solution was stored at room temperature. 
2.2.22 DNAse preparation 
10 mg DNAse (Sigma, USA) were dissolved in 10 ml diluent (0.1 M 
iodoacetic acid, 0.15 M sodium acetate pH 5.2). The prepared solution was heated to 
55 °C for 45 minutes and cooled down to 0 °C. 1 M CaCh were added until its 
concentration is 5 mM. The solution was then aliquoted into microcentrifuge tube and 
stored in - 20 °C. (Sambrook et al, 1989) 
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